| Marque | Novus Biologicals |
| Réf. B-LABO | BL-RE-095551 |
| Réf. fabricant | 18362931 |
| Plage de dosage | 0.16 - 10.0ng/mL |
|---|
| Sensibilité du dosage | 0.06ng/mL |
|---|
| Type de produit | ELISA Kit |
|---|
| Type d’échantillon | Cell Culture Supernatant, Plasma (EDTA, Citrate, Heparin), Serum |
|---|
| Spécificité | The assay detects both natural and recombinant human CD40 Ligand/TNFSF5. The cross reactivity and interference of circulating factors of the immune system was evaluated by spiking these proteins at physiologically relevant concentrations into a human CD40 Ligand/TNFSF5 positive sample. There was no cross reactivity or interference. |
|---|
| Espèces cibles | Human |
|---|
| À utiliser avec (application) | ELISA |
|---|
| Identification génétique (Entrez) | 959 |
|---|
| Symbole de gène(s) | CD40LG |
|---|
| Contenus des kits | Aluminum pouch(es) with a Microwell Plate coated with monoclonal antibody to human sCD40L, HRP-Conjugate anti-human sCD40L monoclonal antibody, Human sCD40L Standard lyophilized, 20ng/mL upon reconstitution, Control high, lyophilized, Control low, lyophilized, Sample Diluent, Assay Buffer Concentrate 20x (PBS with 1% Tween 20 and 10% BSA), Wash Buffer Concentrate 20x (PBS with 1% Tween 20), Substrate Solution (tetramethyl-benzidine), Stop Solution (1M Phosphoric acid), Adhesive Films, Dilution Plates |
|---|
| Quantité | 96 Tests |
|---|
| Disciplines de recherche | Adaptive Immunity, Apoptosis, Asthma, Breast Cancer, Cancer, Cell Biology, Cellular Markers, Endothelial Cell Markers, Hematopoietic Stem Cell Markers, Hypoxia, Immunology, Innate Immunity, Mast Cell Markers, Mesenchymal Stem Cell Markers, Myeloid Cell Ma |
|---|
| Conditions de stockage | Storage of components varies. See protocol for specific instructions. |
|---|
| Synonyme | CD154, CD154 antigen, CD40 antigen ligand, CD40 ligand, CD40-L, CD40LIGM, gp39, hCD40L, HIGM1, T-B cell-activating molecule, T-BAM, T-cell antigen Gp39, TNF-related activation protein, TNFSF5IMD3, TRAPtumor necrosis factor (ligand) superfamily, member 5 ( |
|---|
| Cible | CD40 Ligand/TNFSF5 |